Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Catalyst Pharmaceuticals (CPRX) Shares Outstanding (Diluted Average) (2018 - 2024)

Historic Shares Outstanding (Diluted Average) for Catalyst Pharmaceuticals (CPRX) over the last 7 years, with Q1 2024 value amounting to $123.4 million.

  • Catalyst Pharmaceuticals' Shares Outstanding (Diluted Average) rose 826.2% to $123.4 million in Q1 2024 from the same period last year, while for Mar 2024 it was $123.4 million, marking a year-over-year increase of 826.2%. This contributed to the annual value of $113.8 million for FY2023, which is 213.47% up from last year.
  • Latest data reveals that Catalyst Pharmaceuticals reported Shares Outstanding (Diluted Average) of $123.4 million as of Q1 2024, which was up 826.2% from $113.8 million recorded in Q4 2023.
  • In the past 5 years, Catalyst Pharmaceuticals' Shares Outstanding (Diluted Average) registered a high of $123.4 million during Q1 2024, and its lowest value of $106.2 million during Q4 2020.
  • Over the past 5 years, Catalyst Pharmaceuticals' median Shares Outstanding (Diluted Average) value was $109.0 million (recorded in 2022), while the average stood at $110.4 million.
  • Per our database at Business Quant, Catalyst Pharmaceuticals' Shares Outstanding (Diluted Average) tumbled by 61.53% in 2020 and then skyrocketed by 826.2% in 2024.
  • Over the past 5 years, Catalyst Pharmaceuticals' Shares Outstanding (Diluted Average) (Quarter) stood at $106.2 million in 2020, then increased by 1.46% to $107.8 million in 2021, then increased by 3.32% to $111.4 million in 2022, then rose by 2.13% to $113.8 million in 2023, then rose by 8.48% to $123.4 million in 2024.
  • Its Shares Outstanding (Diluted Average) stands at $123.4 million for Q1 2024, versus $113.8 million for Q4 2023 and $113.8 million for Q3 2023.